Stock Taper
ICLR
ICON PUBLIC LIMITED COMPANY
NASDAQ
$170.02
▲ UP 0.18% (0.30)

KEY STATISTICS

Market Cap$13.02 B
52w High$203.91
52w Low$66.57
Dividend Yield
Frequency
P/E13.87
Volume314.63K
Shares Out.76.57M

COMPANY

LEADERSHIP

Barry Balfe
CHIEF EXECUTIVE
Barry Balfe

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 15, 1998
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
40,200

PRICE TARGET

Target High$207.00
Target Low$105.00
Target Median$175.00
Target Consensus$170.64

UPCOMING EARNINGS

DateOct 28, 2026
DayWednesday
Rev. Est.$2.01B
OCT
28
WED

SPLIT RECORD

DATETYPERATIO
2008-08-13Forward2:1
2006-10-24Forward2:1

PRICE

$170.02 ▲ UP 0.18% (+$0.30)
OVERLAYS
$168$169$1709:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM170.02

About ICON Public Limited Company

https://www.iconplc.com ↗

ICON Public Limited Company is a global CRO offering comprehensive clinical development, management, and analytics services across all trial phases for pharma, biotech, medical devices, and public health clients.

INDUSTRY

Medical - Diagnostics & Research

A SERVICE ICON PUBLIC LIMITED COMPANY IS KNOWN FOR

Clinical Research Services

ICON plc is a global CRO offering comprehensive clinical trial services across all phases, including the expanded Accellacare Site Network for specialized therapeutic areas like oncology, to efficiently support drug and device development.

Revenue by Products

IconPRODUCTQ4-2011Q3-2012Q4-2012
Clinical Research$223.95M $261.52M $766.01M
Central Laboratory$18.67M $23.98M $63.49M

Revenue by Geography

MapREGIONQ4-2022Q1-2023Q2-2023Q4-2023
UNITED STATES$806.76M $844.4M $848.02M $1.59B
IRELAND$589.37M $511.83M $593.41M $1.27B
Rest Of Europe$336.36M $414.22M $373.81M $786.75M
Rest Of World$208.12M $205.01M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity3
Return On Assets3
Debt To Equity2
Price To Earnings1
Price To Book4
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Kevin Hern
Kevin Hern
Sale
2026-03-05
Julia Letlow
Julia Letlow
Sale
2026-02-12
John James
John James
Sale (Full)
2024-09-04

INSIDER TRADES

DIRECTOR
Whitaker Anne Clem
Purchase · 1.3K shares
2026-08-10
DIRECTOR
Whitaker Anne Clem
Sale · 590 shares
2026-08-11
OFFICER: CHIEF FINANCIAL OFFICER
Clerkin Nigel Bernard John
Purchase · 14.2K shares
2026-08-10
OFFICER: CHIEF FINANCIAL OFFICER
Clerkin Nigel Bernard John
Sale · 259 shares
2026-08-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 5
BUY 4
NEUTRAL 2
UNDERPERFORM 1
EQUAL WEIGHT 1
13 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
GH$161.50COMPARE
MEDP$600.65COMPARE
SOLV$91.12COMPARE
NBIX$154.06COMPARE
RVTY$128.80COMPARE
COO$71.17COMPARE
EHC$120.85COMPARE
UHS$171.66COMPARE